news paper icon

Analyzed News

UPDATE 3-Eli Lilly misses sales estimates as top-seller Trulicity disappoints

Eli Lilly and Co's quarterly sales missed Wall Street estimates on Wednesday as the drugmaker offered more discounts or rebates for its top-selling diabetes drug Trulicity, sending shares down 3%. [Source]

Publication Date:


Category: companyNews

Topics: Trulicity, estimates, Lilly, 3-Eli, disappoints, top-seller, UPDATE, misses, sales, quarterly sales, missed, diabetes drug, sending, shares, top-selling, rebates, Street, drugmaker offered, discounts


Related Articles